Analgesics in New Zealand

Analgesics in New Zealand

  • October 2016
  • 25 pages
  • Euromonitor International
Report ID: 149691
2016 saw analgesics face negative media coverage as it was discovered that various pain relief products with the same active ingredients were being marketed for different ailments. In particular, Reckitt Benckiser in Australia was found to be marketing the same active ingredient in different products for specific ailments, such as back pain, neck pain and menstrual pain. The federal court in Australia ordered the company to stop selling some of its products under the Nurofen brand as they contai...

Euromonitor International’s Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=NewZealand Industry=OTC ParentIndustry=Pharmaceutical Date=201610 Topic=MarketReport Publisher=EuromonitorInternational Price=1000